In Praise of Independence: Q&A with Roche's Dan Zabrowski

Roche has always gone its own way: investing in biologics, championing personalized medicine, and checking its ego at the door when doing deals. Now that the rest of Big Pharma has caught on, can a new generation of leaders keep the Swiss giant ahead of its time?
Mar 01, 2008